Mary1 and derivatives thereof for the treatment of mitochondrial dysfunction, vascular injury, kidney diseases, and organ aging

CA3330039A1Pending Publication Date: 2025-11-20THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3330039
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-13
Filing Date
2025-05-13
Publication Date
2025-11-20
Patent Text Reader

Abstract

In one aspect, the disclosure relates to pyridinylpiperazine-based compound MARY1 and derivatives thereof, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating acute kidney injury and reducing senescent changes in the kidney using the same. In one aspect, the disclosed compounds are selective 5-HT2B agonists. In another aspect, the disclosed compounds are useful for stimulating mitochondrial biogenesis.
Need to check novelty before this filing date? Find Prior Art